2013 Update: IPSC & US Cord Blood Banking Industry Reports Available at ReportsnReports.com

“Complete 2012-13 Induced Pluripotent Stem Cell Industry Report” and “Complete 2012-13 U.S. Cord Blood Banking Industry Report” are reports available at ReportsnReports.com store.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Dallas, Texas (PRWEB) March 07, 2013

Stem cell research and experimentation has been in process for well over five decades. Stem cells have the unique characteristics whereby they are able to divide and replicate repeatedly in addition to their being “unspecialized” with the ability to differentiate into specialized cell types. The possibilities that arise with the perfecting of cell replication has caused this area of exploration to remain on the forefront of scientific research, with ongoing hope that cures and treatment of diseases as well as reparative cell therapy, tissue regeneration and pharmacological testing on cell-specific tissue will one day become viable options within the medical community. Diseases such as Huntington’s chorea, Parkinson’s disease, and spinal cord injuries are just some examples of potential clinical applications where stem cells can offer potential benefits in halting or even reversing medical conditions that previously had no positive outcome potential – and induced pluripotent stem cells represent a preferred cell type for this type of disease reversal research.

Traditionally, scientists have worked with both embryonic and adult stem cells. While the appeal of embryonic cells has been their ability to differentiate into any type of cell, there has been significant ethical, moral and spiritual controversy surrounding the use of embryonic cells for research. Although adult stem cells can differentiate slightly, they are typically limited to differentiation within their original tissue type, creating narrow options for their use.

Key Findings Include:

  •     Charts, Timelines, Metrics and Financials for the Induced Pluripotent Stem Cell Research Product Market
  •     Trends for iPSC Grants, Publications, Patents, and More
  •     5-Year Market Projection Data for 2012-2017
  •     Competitive Environment Analysis, Including Market Share by Competitor
  •     Preferred Species for iPSC Research
  •     iPSC Product Categories (Breakdown of Market Share by Each)
  •     Consumer Behavioral Patterns and Preferred Providers
  •     Crucial Trends and Unmet Market Needs
  •      “Tested Sentences” for Selling to iPSC Scientists
  •     Trends in Marketing, Including a Breakdown of the Marketing Methods Used by Your

Competition - Google Ads, Facebook Ads, App Advertising, Purchased Email Lists, Website Advertisements, Trade Journals, and More.

  •     End-User Wants/Needs, Technical Preferences, and Factors Influencing Purchasing Decisions (Survey of iPSC Researchers)

Order this report by March 15, 2013 at ReportsnReports.com and get 25% discount. Buy now @ http://www.reportsnreports.com/purchase.aspx?name=206575.

In summary, this is a must-read industry report for research supply companies to optimally position themselves to sell iPSC research products. To profit from this lucrative and rapidly expanding market, you need to understand your key strengths relative to the competition, intelligently position your products to fill gaps in the market place, and take advantage crucial iPSC trends. Claim this report now to profit from this expanding market- or your competition will.

Complete 2012-13 U.S. Cord Blood Banking Industry Report
Part 1: U.S. Cord Blood Banking Industry - Market Overview & Outlook: Stem cells derived from umbilical blood have been used in more than 30,000 transplants worldwide to treat a wide range of blood diseases, genetic and metabolic disorders, immunodeficiency’s and various forms of cancer. Additionally, cord blood banks now exist in nearly every developed country, as well as several developing nations. However, there is still significant variation within the industry.

First, there is the divide between private and public cord blood banking, in which private companies serve individual families, while public banks serve the broader public. Additionally, some cord blood banks receive only units from nearby hospitals and birthing centers, while others allow mail-in units from a wide geographic region. There is also variation in the services offered by private cord blood banks, with cord tissue storage emerging as a commercial service in 2010, when the Cord Blood Registry began offering it, to complement its cord blood banking services. This trend of cord tissue storage has had a significant impact on the cord blood banking industry, with nine private U.S. companies now offering the service. Finally, there is also significant variation in the quality, pricing, and guarantees promised by U.S. cord blood banks.

This section of the report considers the impact of historical events, the importance of key findings and discoveries on market conditions, and rapidly changing aspects of the industry. It is a roadmap of where the cord blood banking industry has been, what has shaped it, and where it is going. With an understanding of these relevant market conditions, the subsequent sections of this report become “rooted” and relevant.

Part 2: Expansion & Growth – Trailing 12-Month Analysis and Future Projections

Part 3: Parent Survey – Continuing to Grow by Listening to Expectant Parents

Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=178697.

Explore other on Biotechnology Market @ http://www.reportsnreports.com/market-research/biotechnology/.

About US:
ReportsnReports.com is an online market research reports library of 200,000+ in-depth studies of over 5000 micro markets.


Contact

Follow us on: Contact's Facebook Contact's Twitter Contact's LinkedIn Contact's Google Plus

Past News Releases Group Rss Subscribe